194 related articles for article (PubMed ID: 2181375)
1. BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
[TBL] [Abstract][Full Text] [Related]
2. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
[TBL] [Abstract][Full Text] [Related]
3. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
Ali IU; Merlo G; Callahan R; Lidereau R
Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
[TBL] [Abstract][Full Text] [Related]
4. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
5. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.
Tsuda T; Tahara E; Kajiyama G; Sakamoto H; Terada M; Sugimura T
Cancer Res; 1989 Oct; 49(20):5505-8. PubMed ID: 2529025
[TBL] [Abstract][Full Text] [Related]
6. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
7. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
10. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
Tsuda H; Hirohashi S; Shimosato Y; Hirota T; Tsugane S; Yamamoto H; Miyajima N; Toyoshima K; Yamamoto T; Yokota J
Cancer Res; 1989 Jun; 49(11):3104-8. PubMed ID: 2566377
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma.
Adelaide J; Mattei MG; Marics I; Raybaud F; Planche J; De Lapeyriere O; Birnbaum D
Oncogene; 1988 Apr; 2(4):413-6. PubMed ID: 3283658
[TBL] [Abstract][Full Text] [Related]
12. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
[TBL] [Abstract][Full Text] [Related]
13. DNA amplification at 11q13.5-q14 in human breast cancer.
Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
Oncogene; 1992 Dec; 7(12):2513-7. PubMed ID: 1461654
[TBL] [Abstract][Full Text] [Related]
14. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
Meyers SL; O'Brien MT; Smith T; Dudley JP
Cancer Res; 1990 Sep; 50(18):5911-8. PubMed ID: 1975511
[TBL] [Abstract][Full Text] [Related]
16. Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.
Theillet C; Le Roy X; De Lapeyrière O; Grosgeorges J; Adnane J; Raynaud SD; Simony-Lafontaine J; Goldfarb M; Escot C; Birnbaum D
Oncogene; 1989 Jul; 4(7):915-22. PubMed ID: 2474139
[TBL] [Abstract][Full Text] [Related]
17. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
18. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O
Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190
[TBL] [Abstract][Full Text] [Related]
19. Biological significance of the hst-1 gene.
Terada M; Yoshida T; Sakamoto H; Miyagawa K; Katoh O; Hattori Y; Sugimura T
Princess Takamatsu Symp; 1989; 20():71-80. PubMed ID: 2535108
[TBL] [Abstract][Full Text] [Related]
20. Expression of int-2 mRNA in human tumors amplified at the int-2 locus.
Liscia DS; Merlo GR; Garrett C; French D; Mariani-Costantini R; Callahan R
Oncogene; 1989 Oct; 4(10):1219-24. PubMed ID: 2677918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]